4.5 Article

How to deal with vaccine hesitancy?

Journal

VACCINE
Volume 33, Issue 34, Pages 4215-+

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2015.04.043

Keywords

Vaccine hesitancy; WHO; SAGE; Recommendations; Vaccine acceptance; Vaccine refusal

Funding

  1. Novartis
  2. GSK

Ask authors/readers for more resources

Based on the concerns about vaccine hesitancy and its impact on vaccine uptake rates and the performance of national immunization programmes, the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on Vaccine Hesitancy [1], carried out a review, and proposed a set of recommendations directed to the public health community, to WHO and its partners, and to the World Health Organization (WHO) member states. The final recommendations issued by SAGE in October 2014 fall into three categories: (I) those focused on the need to increase the understanding of vaccine hesitancy, its determinants and the rapidly changing challenges it entails; (2) those focused on dealing with the structures and organizational capacity to decrease hesitancy and increase acceptance of vaccines at the global, national and local levels; (3) and those focused on the sharing of lessons learnt and effective practices from various countries and settings as well as the development, validation and implementation of new tools to address hesitancy. (C) 2015 Published by Elsevier Ltd. This is an open access article under the CC BY license.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available